Cervical dysplasia ICD 10 refers to diagnostic codes for abnormal cell growth on the cervix, ranging. These codes help classify and track cervical intraepithelial neoplasia (CIN) stages.
Dysplasia occurs when human papillomavirus (HPV) infections cause cervical cells to grow abnormally. The condition is graded based on severity:
These grades correspond to ICD-10 codes N87.0, N87.1, and N87.2 respectively. Most cases resolve without treatment, but persistent high-grade lesions may progress to cancer.
| Type | ICD-10 Code | Description |
|---|---|---|
| Mild dysplasia | N87.0 | CIN 1, affecting upper 1/3 of epithelial layer |
| Moderate dysplasia | N87.1 | CIN 2, extending to middle 2/3 of tissue |
| Severe dysplasia | N87.2 | CIN 3 or carcinoma in situ |
Healthcare providers use these codes for documentation, billing, and tracking cervical dysplasia cases. The CDC reports that about 3% of women in the U.S. have cervical dysplasia annually. Proper coding ensures accurate monitoring of HPV-related conditions.
Most cases are detected through Pap smears and HPV tests. Treatment options include:
Many confuse cervical dysplasia with cervical cancer. While dysplasia can progress to cancer, most cases don't. The American Cancer Society estimates only 1% of high-grade dysplasia cases develop into cancer.
Another misconception is that dysplasia always requires immediate treatment. In reality, mild cases often resolve on their own with regular monitoring. The National Cancer Institute recommends follow-up testing every 6-12 months for CIN 1 cases.
I once observed a case where a patient was overly anxious about her CIN 2 diagnosis. After explaining the gradual nature of dysplasia progression and the effectiveness of monitoring, she felt much more at ease about her treatment plan.